Cemsidomide, an orally bioavailable degrader, is currently being evaluated in a Phase 1/2 clinical trial as a potential treatment for multiple myeloma and non-Hodgkin's lymphoma. Learn more on our website: https://bit.ly/4bsj5TU #TPD
C4 Therapeutics, Inc.’s Post
More Relevant Posts
-
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study https://lnkd.in/e9mxHeNB
To view or add a comment, sign in
-
-
Trial of cell-based therapy for high-risk lymphoma leads to #FDA breakthrough designation. (via Stanford) https://lnkd.in/eMq3x-y6
To view or add a comment, sign in
-
-
Trial of cell-based therapy for high-risk lymphoma leads to #FDA breakthrough designation. (via Stanford) https://lnkd.in/eMq3x-y6
To view or add a comment, sign in
-
-
Trial of cell-based therapy for high-risk lymphoma leads to #FDA breakthrough designation. (via Stanford) https://lnkd.in/eMq3x-y6
To view or add a comment, sign in
-
-
Multiple Intussusceptions due to Lymphoma From "CT of Lymphoma: Involvement of the GI Tract - Part 2" View the full lecture here: https://lnkd.in/ganUC63h
To view or add a comment, sign in
-
Dr. Jeffrey Bryan is a textbook of knowledge when it comes to lymphoma! In our conversation, he offered a great deal of clarification around diagnostics and some of the newer treatement options for our lymphoma patients as well as the importance of general support for their overall health. Tune in to learn more! 🎙️ https://lnkd.in/euTXZt2i
To view or add a comment, sign in
-
At #ASH23, new three-year data from the ZUMA-12 phase 2 clinical trial was presented, and found that CAR T is effective as first-line therapy for high-risk lymphoma patients. Read more: https://lnkd.in/ez7zVnsP #MoffittASH23
CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients
To view or add a comment, sign in
-
Nuclear Medicine, Molecular Theranostics & Nuclear Thyroidology Specialist, Sarvodaya Hospital and Research Center, Faridabad (Delhi-NCR), India
Amidst the current buzz surrounding Burkitt Lymphoma, I would like to share some insightful perspectives. Let's explore the key facets of this topic together. #burkittlymphoma #lymphoma #cancerawareness #drswagatdash #shrc
To view or add a comment, sign in
-
🔬 EBER+ Stain: Observe an EBER+ stain in a Hodgkin Reed Sternberg cell in a case of classic Hodgkin lymphoma. EBER expression is seen in ~50% of cases, providing valuable insight for differentiating some CD30+ lymphoma. #hemepath #lymphoma #PathTwitter
To view or add a comment, sign in
-
-
JUST IN: FDA investigates potential link between CAR T-cell therapy and T-cell lymphoma cases. Experts emphasize the need for more data. #CARtherapy #TcellLymphoma #MedicalResearch #TheReportify. Share your thoughts in the comments. To learn more and read the complete story, click on this link. https://lnkd.in/gswxHfFc
To view or add a comment, sign in